Exact Mass: 379.1896

Exact Mass Matches: 379.1896

Found 86 metabolites which its exact mass value is equals to given mass value 379.1896, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fumitremorgin C

(1S,12S,15S)-7-methoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C22H25N3O3 (379.1896)


Fumitremorgin C is produced by Aspergillus fumigatus and Neosartorya fischeri. Production by Aspergillus fumigatus and Neosartorya fischeri Fumitremorgin C. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=118974-02-0 (retrieved 2024-08-26) (CAS RN: 118974-02-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

sudan 7b

N-Ethyl-1-[2-[4-(2-phenyldiazenyl)phenyl]diazenyl]-2-naphthalenamine

C24H21N5 (379.1797)


   

Thaumatin b, recombinant

N-{4-[(4-cycloheptylpiperazin-1-yl)sulphonyl]phenyl}ethanimidic acid

C19H29N3O3S (379.193)


Thaumatin b, recombinant is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

Dacinostat

N-hydroxy-3-(4-{[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl}phenyl)prop-2-enamide

C22H25N3O3 (379.1896)


   

Niravoline

N-methyl-2-(3-nitrophenyl)-N-[2-(pyrrolidin-1-yl)-2,3-dihydro-1H-inden-1-yl]acetamide

C22H25N3O3 (379.1896)


   

Sudan Red 7B

N-ethyl-1-{2-[4-(2-phenyldiazen-1-yl)phenyl]diazen-1-yl}naphthalen-2-amine

C24H21N5 (379.1797)


   

Schizanthine A

Schizanthine A

C20H29NO6 (379.1995)


   

Pulchellamine E

Pulchellamine E

C20H29NO6 (379.1995)


   

12-Hydroxy-11-methoxy-N-acetylnor-C-fluorocurarimine

12-Hydroxy-11-methoxy-N-acetylnor-C-fluorocurarimine

C22H25N3O3 (379.1896)


   

Schizanthine K|Schizanthine L

Schizanthine K|Schizanthine L

C20H29NO6 (379.1995)


   

(3Z)-8a-methoxy-3-{[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene}hexahydropyrrolo[1,2-a]pyrazine-1,4-dione|brevianamide R

(3Z)-8a-methoxy-3-{[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene}hexahydropyrrolo[1,2-a]pyrazine-1,4-dione|brevianamide R

C22H25N3O3 (379.1896)


   

11-O-acetyl bulgarsenine hydrochloride

11-O-acetyl bulgarsenine hydrochloride

C20H29NO6 (379.1995)


   

schizanthine K

schizanthine K

C20H29NO6 (379.1995)


   
   
   

(N2,N2-dimethyl-L-phenylalanyl)-L-tryptophan

(N2,N2-dimethyl-L-phenylalanyl)-L-tryptophan

C22H25N3O3 (379.1896)


   

O-acetylyamataimine

O-acetylyamataimine

C20H29NO6 (379.1995)


   

C22H25N3O3_9-Methoxy-12-(2-methyl-1-propen-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5H,14H-pyrrolo[1,2:4,5]pyrazino[1,2:1,6]pyrido[3,4-b]indole-5,14-dione

NCGC00380742-01_C22H25N3O3_9-Methoxy-12-(2-methyl-1-propen-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5H,14H-pyrrolo[1,2:4,5]pyrazino[1,2:1,6]pyrido[3,4-b]indole-5,14-dione

C22H25N3O3 (379.1896)


   

Fumitremorgin C

Fumitremorgin C

C22H25N3O3 (379.1896)


An organic heteropentacyclic compound that is a mycotoxic indole alkaloid produced by several fungi. A potent and specific inhibitor of the breast cancer resistance protein multidrug transporter.

   

Thaumatin b, recombinant

N-[4-(4-cycloheptylpiperazine-1-sulfonyl)phenyl]acetamide

C19H29N3O3S (379.193)


   

3-Fluoro-4-cyanophenyl trans-4- (4-n-butylcyclohexyl)benzoate

3-Fluoro-4-cyanophenyl trans-4- (4-n-butylcyclohexyl)benzoate

C24H26FNO2 (379.1947)


   

7-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-5H-[1,3]dioxolo[4,5-f]indole

7-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-5H-[1,3]dioxolo[4,5-f]indole

C22H25N3O3 (379.1896)


   

2-HYDROXY-4-METHYL PYRIDINE

2-HYDROXY-4-METHYL PYRIDINE

C21H30ClNO3 (379.1914)


   

Spiroxatrine

Spiroxatrine

C22H25N3O3 (379.1896)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists Spiroxatrine (R 5188) is a selective, dual antagonist of 5-HT1α and α2-adrenergic, with the Ki values of 3.94, 224000, 118.5 nM for 5-HT1α, 5-HT1β and 5-HT2, respectively. Spiroxatrine (R 5188) has a sedative effect[1][2][3][4].

   

(3-[(ACRIDINE-9-CARBONYL)-AMINO]-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER

(3-[(ACRIDINE-9-CARBONYL)-AMINO]-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER

C22H25N3O3 (379.1896)


   

N-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine,hydrochloride

N-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine,hydrochloride

C21H30ClNO3 (379.1914)


   
   

N-(2-hydroxy-1-methyl-2-phenylethyl)-N,7,7-trimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulphonamide

N-(2-hydroxy-1-methyl-2-phenylethyl)-N,7,7-trimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulphonamide

C20H29NO4S (379.1817)


   
   

Methyl Violet 2B

Methyl Violet 2B

C23H26ClN3 (379.1815)


   

4-{4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZIN-1-YL}PHENYLAMINE

4-{4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZIN-1-YL}PHENYLAMINE

C23H23F2N3 (379.186)


   

Z-L-aspartic acid di-tert·butyl ester

Z-L-aspartic acid di-tert·butyl ester

C20H29NO6 (379.1995)


   

Trimethoxy Dobutamine Hydrochloride

Trimethoxy Dobutamine Hydrochloride

C21H30ClNO3 (379.1914)


   

Dacinostat

Dacinostat

C22H25N3O3 (379.1896)


C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   

1-Piperazinepropanoic acid, 4-dibenz(b,f)(1,4)oxazepin-11-yl-alpha,alpha-dimethyl-

1-Piperazinepropanoic acid, 4-dibenz(b,f)(1,4)oxazepin-11-yl-alpha,alpha-dimethyl-

C22H25N3O3 (379.1896)


   

Thaumatin b, recombinant

N-{4-[(4-cycloheptylpiperazin-1-yl)sulphonyl]phenyl}ethanimidic acid

C19H29N3O3S (379.193)


Thaumatin b, recombinant is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents

   

ethyl N-[(E)-[1-[3-(4-methylphenoxy)propyl]indol-3-yl]methylideneamino]carbamate

ethyl N-[(E)-[1-[3-(4-methylphenoxy)propyl]indol-3-yl]methylideneamino]carbamate

C22H25N3O3 (379.1896)


   

N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-2-(3-oxo-1,4-benzoxazin-4-yl)acetamide

N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-2-(3-oxo-1,4-benzoxazin-4-yl)acetamide

C22H25N3O3 (379.1896)


   

2-Methyl-1-phenyl-5-benzimidazolecarboxylic acid [2-(3-methylbutan-2-ylamino)-2-oxoethyl] ester

2-Methyl-1-phenyl-5-benzimidazolecarboxylic acid [2-(3-methylbutan-2-ylamino)-2-oxoethyl] ester

C22H25N3O3 (379.1896)


   

1-(1,4-dioxan-2-yl)-N-[[3-(diphenylmethyl)-1,2,4-oxadiazol-5-yl]methyl]-N-methylmethanamine

1-(1,4-dioxan-2-yl)-N-[[3-(diphenylmethyl)-1,2,4-oxadiazol-5-yl]methyl]-N-methylmethanamine

C22H25N3O3 (379.1896)


   

N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-5-(methoxymethyl)-2-furancarboxamide

N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-5-(methoxymethyl)-2-furancarboxamide

C22H25N3O3 (379.1896)


   

(2S,3R,4R)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

(2S,3R,4R)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

C22H25N3O3 (379.1896)


   

(2S,3S,4R)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

(2S,3S,4R)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

C22H25N3O3 (379.1896)


   

(2R,3R,4R)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

(2R,3R,4R)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

C22H25N3O3 (379.1896)


   

N-(cyclopropylmethyl)-2-[(2R,5R,6S)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

N-(cyclopropylmethyl)-2-[(2R,5R,6S)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H26FN3O4 (379.1907)


   

N-(cyclopropylmethyl)-2-[(2S,5S,6S)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

N-(cyclopropylmethyl)-2-[(2S,5S,6S)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H26FN3O4 (379.1907)


   

N-(cyclopropylmethyl)-2-[(2R,5S,6S)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

N-(cyclopropylmethyl)-2-[(2R,5S,6S)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H26FN3O4 (379.1907)


   

(2R,3S,4R)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

(2R,3S,4R)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

C22H25N3O3 (379.1896)


   

(2S,3S,4S)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

(2S,3S,4S)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

C22H25N3O3 (379.1896)


   

N-(cyclopropylmethyl)-2-[(2S,5R,6S)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

N-(cyclopropylmethyl)-2-[(2S,5R,6S)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H26FN3O4 (379.1907)


   

N-(cyclopropylmethyl)-2-[(2R,5S,6R)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

N-(cyclopropylmethyl)-2-[(2R,5S,6R)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H26FN3O4 (379.1907)


   

N-(cyclopropylmethyl)-2-[(2S,5S,6R)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

N-(cyclopropylmethyl)-2-[(2S,5S,6R)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H26FN3O4 (379.1907)


   

N-(cyclopropylmethyl)-2-[(2R,5R,6R)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

N-(cyclopropylmethyl)-2-[(2R,5R,6R)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H26FN3O4 (379.1907)


   

N-(cyclopropylmethyl)-2-[(2S,5R,6R)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

N-(cyclopropylmethyl)-2-[(2S,5R,6R)-5-[[(3-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]acetamide

C19H26FN3O4 (379.1907)


   

(2R,3S,4S)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

(2R,3S,4S)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-(2-methoxyphenyl)phenyl]-2-azetidinecarbonitrile

C22H25N3O3 (379.1896)


   

beta-D-Tyvp-(1->3)-beta-D-GalpNAc6,OMe2

beta-D-Tyvp-(1->3)-beta-D-GalpNAc6,OMe2

C16H29NO9 (379.1842)


   

beta-D-Tyvp2Me-(1->3)-beta-D-GalpNAc-OMe

beta-D-Tyvp2Me-(1->3)-beta-D-GalpNAc-OMe

C16H29NO9 (379.1842)


   

Dodecanal O-[(pentafluorophenyl)methyl]oxime

Dodecanal O-[(pentafluorophenyl)methyl]oxime

C19H26F5NO (379.1934)


   

thaumatin

thaumatin

C19H29N3O3S (379.193)


D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents

   

12alpha-Fumitremorgin C

12alpha-Fumitremorgin C

C22H25N3O3 (379.1896)


   

ST 18:2;O4;Gly

ST 18:2;O4;Gly

C20H29NO6 (379.1995)


   

ML417

ML417

C22H25N3O3 (379.1896)


ML417 is a selective and brain penetrant D3 dopamine receptor (D3R) agonist, with an EC50 of 38 nM. ML417 potently promotes D3R-mediated β-arrestin translocation, G protein mediated signaling, and pERK phosphorylation with minimal effects on other GPCR-mediated signaling. ML417 exhibits neuroprotection against toxin-induced neurodegeneration of dopaminergic neurons[1]. ML417 is a selective and brain penetrant D3 dopamine receptor (D3R) agonist, with an EC50 of 38 nM. ML417 potently promotes D3R-mediated β-arrestin translocation, G protein mediated signaling, and pERK phosphorylation with minimal effects on other GPCR-mediated signaling. ML417 exhibits neuroprotection against toxin-induced neurodegeneration of dopaminergic neurons[1].

   

1-hydroxy-8a-methoxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

1-hydroxy-8a-methoxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

C22H25N3O3 (379.1896)


   

3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C22H25N3O3 (379.1896)


   

1-[(1r,11s,12e,17s)-10-carboximidoyl-12-ethylidene-6-hydroxy-5-methoxy-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2(7),3,5,9-tetraen-8-yl]ethanone

1-[(1r,11s,12e,17s)-10-carboximidoyl-12-ethylidene-6-hydroxy-5-methoxy-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2(7),3,5,9-tetraen-8-yl]ethanone

C22H25N3O3 (379.1896)


   

1-ethyl 8-methyl-6-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enedioate

1-ethyl 8-methyl-6-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enedioate

C20H29NO6 (379.1995)


   

(3z)-1-hydroxy-8a-methoxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

(3z)-1-hydroxy-8a-methoxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

C22H25N3O3 (379.1896)


   

3-(5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl)-n-(2-phenylethyl)propanimidic acid

3-(5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl)-n-(2-phenylethyl)propanimidic acid

C22H25N3O3 (379.1896)


   

1-ethyl (3r,6r)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate

1-ethyl (3r,6r)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate

C20H29NO6 (379.1995)


   

(3z,8ar)-1-hydroxy-8a-methoxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

(3z,8ar)-1-hydroxy-8a-methoxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one

C22H25N3O3 (379.1896)


   

1-ethyl 8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 3-methylbut-2-enedioate

1-ethyl 8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 3-methylbut-2-enedioate

C20H29NO6 (379.1995)


   

3-[(2r,5r)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[(2r,5r)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C22H25N3O3 (379.1896)


   

7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-5,7a-dihydro-3h-pyrrolizin-1-yl 2-methylbut-2-enoate

7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-5,7a-dihydro-3h-pyrrolizin-1-yl 2-methylbut-2-enoate

C20H29NO6 (379.1995)


   

(1r,4z,7r,8r,12s,18r)-5,7,8-trimethyl-3,9-dioxo-2,10-dioxa-15-azatricyclo[10.5.1.0¹⁵,¹⁸]octadec-4-en-8-yl acetate

(1r,4z,7r,8r,12s,18r)-5,7,8-trimethyl-3,9-dioxo-2,10-dioxa-15-azatricyclo[10.5.1.0¹⁵,¹⁸]octadec-4-en-8-yl acetate

C20H29NO6 (379.1995)


   

1-ethyl (1s,3s,5r,6s)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate

1-ethyl (1s,3s,5r,6s)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate

C20H29NO6 (379.1995)


   

1-ethyl (1s,3s,5r,6s)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate

1-ethyl (1s,3s,5r,6s)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate

C20H29NO6 (379.1995)


   

3-[(2s,5r)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[(2s,5r)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C22H25N3O3 (379.1896)


   

1-ethyl (1r,3r,5s,6s)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-methylbut-2-enedioate

1-ethyl (1r,3r,5s,6s)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-methylbut-2-enedioate

C20H29NO6 (379.1995)


   

7-methoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

7-methoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C22H25N3O3 (379.1896)


   

3-[(2r,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

3-[(2r,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]-n-(2-phenylethyl)propanimidic acid

C22H25N3O3 (379.1896)


   

4-ethyl-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate

4-ethyl-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate

C20H29NO6 (379.1995)


   

(7ar)-7-({[(2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-5,7a-dihydro-3h-pyrrolizin-1-yl (2e)-2-methylbut-2-enoate

(7ar)-7-({[(2r)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-5,7a-dihydro-3h-pyrrolizin-1-yl (2e)-2-methylbut-2-enoate

C20H29NO6 (379.1995)


   

5,7,8-trimethyl-3,9-dioxo-2,10-dioxa-15-azatricyclo[10.5.1.0¹⁵,¹⁸]octadec-4-en-8-yl acetate

5,7,8-trimethyl-3,9-dioxo-2,10-dioxa-15-azatricyclo[10.5.1.0¹⁵,¹⁸]octadec-4-en-8-yl acetate

C20H29NO6 (379.1995)


   

(1r,4s,6s,7s,17r)-4-ethyl-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate

(1r,4s,6s,7s,17r)-4-ethyl-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate

C20H29NO6 (379.1995)


   

1-ethyl 8-methyl-6-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate

1-ethyl 8-methyl-6-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate

C20H29NO6 (379.1995)


   

1-ethyl (1s,3s,5r,6s)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate

1-ethyl (1s,3s,5r,6s)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate

C20H29NO6 (379.1995)